TY  - GEN
AU  - Lee,Ji-Yong
AU  - Kang,Cheol-In
AU  - Ko,Jae-Hoon
AU  - Lee,Woo Joo
AU  - Seok,Hye-Ri
AU  - Park,Ga Eun
AU  - Cho,Sun Young
AU  - Ha,Young Eun
AU  - Chung,Doo Ryeon
AU  - Lee,Nam Yong
AU  - Peck,Kyong Ran
AU  - Song,Jae-Hoon
TI  - Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy
SN  - 1098-6596
PY  - 2017///0818
KW  - Acinetobacter baumannii
KW  - drug effects
KW  - Adult
KW  - Aged
KW  - Anti-Bacterial Agents
KW  - therapeutic use
KW  - Bacteremia
KW  - complications
KW  - Case-Control Studies
KW  - Cross Infection
KW  - Female
KW  - Gram-Negative Bacterial Infections
KW  - Hematologic Neoplasms
KW  - Humans
KW  - Immunosuppressive Agents
KW  - adverse effects
KW  - Intensive Care Units
KW  - Length of Stay
KW  - statistics & numerical data
KW  - Levofloxacin
KW  - Male
KW  - Middle Aged
KW  - Neutropenia
KW  - Pseudomonas aeruginosa
KW  - Respiratory Tract Infections
KW  - Risk Factors
KW  - Stenotrophomonas maltophilia
KW  - Survival Analysis
KW  - Tertiary Care Centers
KW  - Trimethoprim, Sulfamethoxazole Drug Combination
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1128/AAC.00984-16
ER  -